Serum Lp Al lipoprotein particles and other antiatherogenic lipid parameters in normolipidaemic obese subjects

被引:0
|
作者
Lecerf, JM
Masson, A
Fruchart, JC
Bard, JM
机构
[1] INST PASTEUR, SERV EXPERTISE PHARMACOL SERLIA, F-59019 LILLE, FRANCE
[2] INST PASTEUR, INSERM, U325, F-59019 LILLE, FRANCE
关键词
obesity; cardiovascular risk; HDL-cholesterol; apoprotein Al; lipoprotein Al; lipoprotein particles; adipose tissue distribution;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The android pattern oi body fat distribution has been shown to increase the risk of metabolic and coronary heart disease. Protective lipid markers against cardiovascular disease were studied in 98 obese normolipidaemic, non diabetic, non-smoker subjects over 18 years of age according to regional distribution of adipose tissue as estimated by the waist:hip ratio (WHR) and overall obesity as estimated by the body mass index (BMI). WHR was inversely correlated with Lp Al (r = -0.46) and HDL-cholesterol (r = -0.37). BMI was not correlated with protective lipid parameters but only with triglycerides. After adjustment, Lp Al was lower in men and in upper body obese women (p < 0.05). Lp Al is a better indicator of body fat distribution than HDL-cholesterol or apo Al, and its variations appear to be indirectly related to gender, menopause, and age, thereby influencing body fat distribution (the main factor accounting for Lp Al variation). Lp Al was inversely correlated with WHR in gluteal-femoral obese women but not in abdominally obese women or men, possibly because of a threshold effect.
引用
收藏
页码:331 / 340
页数:10
相关论文
共 50 条
  • [21] Correlation of P-selectin and lipoprotein(a), and other lipid parameters in preeclampsia
    H. Aksoy
    Y. Kumtepe
    F. Akçay
    A. K. Yildirim
    Clinical and Experimental Medicine, 2002, 2 : 39 - 43
  • [22] PRONOUNCED LOWERING OF SERUM LEVELS OF LIPOPROTEIN LP(A) IN HYPERLIPEMIC SUBJECTS TREATED WITH NICOTINIC-ACID
    CARLSON, LA
    HAMSTEN, A
    ASPLUND, A
    JOURNAL OF INTERNAL MEDICINE, 1989, 226 (04) : 271 - 276
  • [23] The effect of almonds on the serum lipid, lipoprotein and apolipoprotein levels in Japanese male subjects
    Yanagisawa, C.
    Uto, H.
    Tani, M.
    Kishimoto, Y.
    Machida, N.
    Hasegawa, M.
    Yoshioka, E.
    Kido, T.
    Lapsley, K. G.
    Kondo, K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 434 - 434
  • [24] Influence of heat exposure on serum lipid and lipoprotein cholesterol in young male subjects
    Yamamoto, H
    Zheng, KC
    Ariizumi, M
    INDUSTRIAL HEALTH, 2003, 41 (01) : 1 - 7
  • [25] Lipoprotein (a) concentrations in Greek hyperlipidaemic patients: relationship to serum lipid parameters
    Bairaktari, ET
    Hatzidimou, K
    Elisaf, MS
    EUROPEAN HEART JOURNAL, 1999, 20 (24) : 1844 - 1844
  • [26] SERUM-LIPID AND LIPOPROTEIN PARAMETERS IN PATIENTS WITH PERIPHERAL VASCULAR ATHEROSCLEROSIS
    PRISTAUTZ, H
    PILGER, E
    KOSTNER, GM
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1981, 19 (08): : 806 - 807
  • [27] The effect of orlistat on the fatty acid composition of serum lipid fractions in obese subjects
    Vidgren, HM
    Ågren, JJ
    Valve, RS
    Karhunen, LJ
    Rissanen, AM
    Uusitupa, MIJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (03) : 315 - 322
  • [28] CONNECTION OF ANTHROPOLOGICAL DATA WITH LIPID AND LIPOPROTEIN PARAMETERS IN OBESE-HYPERTONIC AND NORMOTONIC CHILDREN
    CZINNER, A
    TICHY, M
    BARTA, L
    ANTHROPOLOGIAI KOZLEMENYEK-ANTHROPOLOGICAL COMMUNICATIONS, 1983, 27 (01): : 45 - 49
  • [29] Nandrolone decanoate reduces lipoprotein(a) levels without effect on other lipid parameters
    Wolffenbuttel, BHR
    Hartgens, F
    Rietjens, G
    Keizer, HA
    Kuipers, H
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 152 - 152
  • [30] LP(A) COMPARED WITH OTHER LIPID PARAMETERS IN PATIENTS WITH AND WITHOUT ANGIOGRAPHY-PROVEN ATHEROSCLEROSIS
    VANLENTE, F
    GNEZDA, A
    WALETZKY, JA
    GERKEN, KL
    CLINICAL CHEMISTRY, 1990, 36 (06) : 967 - 967